InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: couldbebetter post# 185099

Tuesday, 04/02/2019 9:55:49 PM

Tuesday, April 02, 2019 9:55:49 PM

Post# of 427207
cbb...

Quote: 'Any company acquiring AMRN would have Vascepa sold
by reps who have contact with Cardiologists and Endocrinologists.
Most reps have regular contact with their doctor clientele"..

You talk like an expert, but you really don't know what you are talking about. Medicine is changing and there are fewer and fewer doctors in solo practice..More and more doctors work for consortium and the trend is for the managers of these group practices is to restrict access to the doctors..If you knew anything about the subject you would know that..

We have people that were in the business who have validated that fact on this web site and if you not so busy writing your buy out scenarios you would have read them...

Having been a clinician in practice for many years I know a lot more about drug reps than you or most of the posters on this board..Drug reps don't "educate doctors" or I should say I would not want to be treated by a doctor who got his education from drug reps...

IMO drug reps are a waste of money...by the same token Doctors like Bhatt are worth their weight in gold...

":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News